168 related articles for article (PubMed ID: 2154990)
1. Stimulation by gamma-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II.
Fossé P; René B; Saucier JM; Nguyen CH; Bisagni E; Paoletti C
Biochem Pharmacol; 1990 Feb; 39(4):669-76. PubMed ID: 2154990
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.
Fossé P; René B; Charra M; Paoletti C; Saucier JM
Mol Pharmacol; 1992 Oct; 42(4):590-5. PubMed ID: 1331751
[TBL] [Abstract][Full Text] [Related]
3. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
Fossé P; Charra M; Paoletti C; Saucier JM; René B
Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G
Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183
[TBL] [Abstract][Full Text] [Related]
5. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
Tewey KM; Chen GL; Nelson EM; Liu LF
J Biol Chem; 1984 Jul; 259(14):9182-7. PubMed ID: 6086625
[TBL] [Abstract][Full Text] [Related]
6. A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent.
Pognan F; Saucier JM; Paoletti C; Kaczmarek L; Nantka-Namirski P; Mordarski M; Peczynska-Czoch W
Biochem Pharmacol; 1992 Dec; 44(11):2149-55. PubMed ID: 1335251
[TBL] [Abstract][Full Text] [Related]
7. The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity on isolated nuclei.
Vilarem MJ; Riou JF; Multon E; Gras MP; Larsen CJ
Biochem Pharmacol; 1986 Jul; 35(13):2087-95. PubMed ID: 3015146
[TBL] [Abstract][Full Text] [Related]
8. A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents.
O'Reilly EK; Kreuzer KN
Biochemistry; 2002 Jun; 41(25):7989-97. PubMed ID: 12069589
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators. Simplified analogues of ellipticine derivatives.
Pierson V; Pierre A; de Cointet P; Nguyen CH; Bisagni E; Gros P
Biochem Pharmacol; 1989 May; 38(9):1395-406. PubMed ID: 2719718
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of site-specific topoisomerase II-mediated DNA cleavage by an N-methylpyrrolecarboxamide-anilinoacridine conjugate: relation to DNA binding.
Fossé P; René B; Saucier JM; Hénichart JP; Waring MJ; Colson P; Houssier C; Bailly C
Biochemistry; 1994 Aug; 33(33):9865-74. PubMed ID: 8060993
[TBL] [Abstract][Full Text] [Related]
11. Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.
Fossé P; René B; Le Bret M; Paoletti C; Saucier JM
Nucleic Acids Res; 1991 Jun; 19(11):2861-8. PubMed ID: 1647520
[TBL] [Abstract][Full Text] [Related]
12. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol.
Yamashita Y; Kawada S; Nakano H
Biochem Pharmacol; 1990 Feb; 39(4):737-44. PubMed ID: 2154993
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.
Nahon E; Best-Belpomme M; Saucier JM
Eur J Biochem; 1993 Nov; 218(1):95-102. PubMed ID: 8243480
[TBL] [Abstract][Full Text] [Related]
14. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.
Hong G; Kreuzer KN
Mol Cell Biol; 2000 Jan; 20(2):594-603. PubMed ID: 10611238
[TBL] [Abstract][Full Text] [Related]
15. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
Pommier Y; Capranico G; Orr A; Kohn KW
J Mol Biol; 1991 Dec; 222(4):909-24. PubMed ID: 1662289
[TBL] [Abstract][Full Text] [Related]
16. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.
Yamashita Y; Kawada S; Fujii N; Nakano H
Biochemistry; 1991 Jun; 30(24):5838-45. PubMed ID: 1646001
[TBL] [Abstract][Full Text] [Related]
17. Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
Pommier Y; Minford JK; Schwartz RE; Zwelling LA; Kohn KW
Biochemistry; 1985 Nov; 24(23):6410-6. PubMed ID: 3002440
[TBL] [Abstract][Full Text] [Related]
18. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
Rene B; Fosse P; Khelifa T; Jacquemin-Sablon A; Bailly C
Mol Pharmacol; 1996 Feb; 49(2):343-50. PubMed ID: 8632768
[TBL] [Abstract][Full Text] [Related]
19. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
Cline SD; Macdonald TL; Osheroff N
Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
[TBL] [Abstract][Full Text] [Related]
20. DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives.
Monnot M; Mauffret O; Simon V; Lescot E; Psaume B; Saucier JM; Charra M; Belehradek J; Fermandjian S
J Biol Chem; 1991 Jan; 266(3):1820-9. PubMed ID: 1846365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
